Donovan Joanne M.
SEC insider (Form 3/4/5 filer). CIK 0001644087. CMO at Edgewise Therapeutics, Inc. (EWTX). 26 reported Form 4/5 transactions since Sep 2024; latest on Aug 13, 2026. Located in BOULDER, CO.
Companies Donovan Joanne M. has filed insider reports for
- Edgewise Therapeutics, Inc. (EWTX): Officer, CMO
Donovan Joanne M.
CIK: 0001644087
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Edgewise Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (26 total)
- Aug 13, 2026EWTX
Edgewise Therapeutics, Inc.
SaleDirect2.9K shares at avg. $43.41$127K - Aug 12, 2026EWTX
Edgewise Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
65K shares- - Aug 12, 2026EWTX
Edgewise Therapeutics, Inc.
SaleDirect2.8K shares at avg. $43.78$124K - Aug 12, 2026EWTX
Edgewise Therapeutics, Inc.
AwardDirectRestricted Stock Units
32.5K shares- - Aug 12, 2026EWTX
Edgewise Therapeutics, Inc.
SaleDirect800 shares at avg. $44.52$36K - Aug 12, 2026EWTX
Edgewise Therapeutics, Inc.
SaleDirect2.8K shares at avg. $43.71$121K - Aug 12, 2026EWTX
Edgewise Therapeutics, Inc.
ExerciseDirect5.8K shares- - Aug 12, 2026EWTX
Edgewise Therapeutics, Inc.
ExerciseDirect7K shares- - Aug 12, 2026EWTX
Edgewise Therapeutics, Inc.
SaleDirect104 shares at avg. $44.43$5K - Aug 12, 2026EWTX
Edgewise Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
65K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 13, 2026 | EWTX Edgewise Therapeutics, Inc. | Sale | 2,919 | $43.41 | $126,704 | Direct |
| Aug 12, 2026 | EWTX Edgewise Therapeutics, Inc. | Award Stock Option (Right to Buy) | 65,000 | - | - | Direct |
| Aug 12, 2026 | EWTX Edgewise Therapeutics, Inc. | Sale | 2,839 | $43.78 | $124,303 | Direct |
| Aug 12, 2026 | EWTX Edgewise Therapeutics, Inc. | Award Restricted Stock Units | 32,500 | - | - | Direct |
| Aug 12, 2026 | EWTX Edgewise Therapeutics, Inc. | Sale | 800 | $44.52 | $35,614 | Direct |
| Aug 12, 2026 | EWTX Edgewise Therapeutics, Inc. | Sale | 2,779 | $43.71 | $121,463 | Direct |
| Aug 12, 2026 | EWTX Edgewise Therapeutics, Inc. | Exercise | 5,781 | - | $0 | Direct |
| Aug 12, 2026 | EWTX Edgewise Therapeutics, Inc. | Exercise | 7,031 | - | $0 | Direct |
| Aug 12, 2026 | EWTX Edgewise Therapeutics, Inc. | Sale | 104 | $44.43 | $4,620 | Direct |
| Aug 12, 2026 | EWTX Edgewise Therapeutics, Inc. | Award Stock Option (Right to Buy) | 65,000 | - | - | Direct |
1-10 of 26 transactions